Deciphera is Drug Discovery in United States that focus on Deciphera Pharmaceuticals Inc business. Founded in 2003. They cover business area such as Deciphera Pharmaceuticals Inc, kinase-inhibit drug, cancer, immunological disease, a diverse pipeline, drug candidate, three clinical-stage, two research-stage program, mutant or amplify KIT, Pdgfra, gastrointestinal stromal tumor, advanced systemic mastocytosis, glioma, addition, Rebastinib.
2003
( 21 years old in 2024 )
Deciphera Pharmaceuticals Inc
-
200 Smith Street
Waltham, MA 02451
United States
Private
Deciphera Pharmaceuticals Inckinase-inhibit drugcancerimmunological diseasea diverse pipelinedrug candidatethree clinical-stagetwo research-stage programmutant or amplify KITPdgfragastrointestinal stromal tumoradvanced systemic mastocytosisgliomaadditionRebastinib
* We use standard office opening hours in near Deciphera's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Deciphera is Drug Discovery business from United States that founded in 2003 (21 years old in 2024), Deciphera business is focusing on Deciphera Pharmaceuticals Inc.
Deciphera headquarter office and corporate office address is located in 200 Smith Street Waltham, MA 02451 United States.
Deciphera was founded in United States.
In 2024, Deciphera is currently focus on Deciphera Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Deciphera Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Deciphera, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
